At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:22 ET
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 11,941,763 common shares of NewAmsterdam Pharma (NAMS) as of September 30, 2026, representing 10.0% of shares outstanding. This is an increase from the prior filing (August 2026) which reported 11,931,218 shares (10.0%), reflecting a net addition of approximately 10,545 shares. The filing remains a passive stake with no change in control intent.
- FMR LLC (Fidelity) reported beneficial ownership of 11,941,763 shares of NewAmsterdam Pharma common stock as of September 30, 2026.
- The stake represents 10.0% of the outstanding shares.
- This is an increase of approximately 10,545 shares from the prior filing (11,931,218 shares as of June 30, 2026).
- The filing is a passive Schedule 13G/A, indicating no intent to change or influence control of the issuer.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access